The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

To support tenants using AI, life sciences buildings need increased slab loads, electricity and water, all expensive upgrades for owners.

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

For a stock that had been struggling for significance for much of the past year, this dramatic shift was not merely a rally — ...

Biotech Showcase™ returns to San Francisco during J.P. Morgan Healthcare Week, marking its 19 th year as a premier ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. PALO ALTO, Calif. — At an annual meeting usually focused on the industry’s future, ...

The day that Athena Countouriotis, then the CEO of Turning Point Therapeutics, announced that the San Diego biotech was acquired by Bristol Myers Squibb for $4.1 billion, people were already asking ...

Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...

GSK alum Dr. Ellen Horste’s time investigating fundamental biological questions prepared her for a career in the emerging field of gene therapy. Ellen Horste’s job is a little bit like packing for ...

Sartorius Group is expected to continue delivering high-single digit CER sales growth in 2026, supported by strong consumables performance. JPMorgan maintains an Overweight rating with price targets ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...